Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADequate AntiPlatelet and Anticoagulation Therapy in Atrial Fibrillation Patients With Focus on Ischemic Risk Management A Randomized ADAPT AFFIRM Study

NCT06866665 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT06866665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06866665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADequate AntiPlatelet and Anticoagulation Therapy in Atrial Fibrillation Patients With Focus on Ischemic Risk Management A Randomized ADAPT AFFIRM Study
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
December 31, 2030
Enrollment
1,400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, coronary artery disease